BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16538981)

  • 1. Osmotic nephropathy resulting from maltose-based intravenous immunoglobulin therapy.
    Chacko B; John GT; Balakrishnan N; Kirubakaran MG; Jacob CK
    Ren Fail; 2006; 28(2):193-5. PubMed ID: 16538981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin-induced osmotic nephrosis.
    Ahsan N; Palmer BF; Wheeler D; Greenlee RG; Toto RD
    Arch Intern Med; 1994 Sep; 154(17):1985-7. PubMed ID: 8074604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute renal failure related to intravenous immunoglobulin infusion in an elderly woman.
    Kwan TH; Tong MK; Siu YP; Leung KT; Lee HK; Yung CY; Au TC
    Hong Kong Med J; 2005 Feb; 11(1):45-9. PubMed ID: 15687516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis.
    Hansen-Schmidt S; Silomon J; Keller F
    Am J Kidney Dis; 1996 Sep; 28(3):451-3. PubMed ID: 8804246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk.
    Dantal J
    Am J Nephrol; 2013; 38(4):275-84. PubMed ID: 24051350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous immunoglobulins and acute renal failure: mechanism and prevention].
    Fakhouri F
    Rev Med Interne; 2007 May; 28 Spec No. 1():4-6. PubMed ID: 17768831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute renal failure following immunoglobulin therapy.
    Ahsan N; Wiegand LA; Abendroth CS; Manning EC
    Am J Nephrol; 1996; 16(6):532-6. PubMed ID: 8955767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute renal failure following intravenous immunoglobulin therapy in a HIV-infected patient.
    Metallidis S; Papaioannou M; Bokolas G; Kollaras P; Gogou V; Nikolaidis P
    Clin Nephrol; 2009 Feb; 71(2):196-7. PubMed ID: 19203515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin and the kidney--a two-edged sword.
    Orbach H; Tishler M; Shoenfeld Y
    Semin Arthritis Rheum; 2004 Dec; 34(3):593-601. PubMed ID: 15609263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute renal failure after large doses of intravenous immune globulin.
    Haskin JA; Warner DJ; Blank DU
    Ann Pharmacother; 1999; 33(7-8):800-3. PubMed ID: 10466908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes.
    Dickenmann M; Oettl T; Mihatsch MJ
    Am J Kidney Dis; 2008 Mar; 51(3):491-503. PubMed ID: 18295066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin-associated acute renal failure: case series and literature review.
    Itkin YM; Trujillo TC
    Pharmacotherapy; 2005 Jun; 25(6):886-92. PubMed ID: 15927908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL/lpr mouse model of systemic lupus.
    Racz Z; Nagy E; Rosivall L; Szebeni J; Hamar P
    Lupus; 2010 Apr; 19(5):599-612. PubMed ID: 20167630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute renal failure resulting from intravenous immunoglobulin therapy.
    Tan E; Hajinazarian M; Bay W; Neff J; Mendell JR
    Arch Neurol; 1993 Feb; 50(2):137-9. PubMed ID: 8431131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophagelike vacuolated renal tubular cells in the urine of a male with osmotic nephrosis associated with intravenous immunoglobulin therapy. A case report.
    Khalil M; Shin HJ; Tan A; DuBose TD; Ordóñez N; Katz RL
    Acta Cytol; 2000; 44(1):86-90. PubMed ID: 10667167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute renal failure associated with immunoglobulin therapy.
    Cantú TG; Hoehn-Saric EW; Burgess KM; Racusen L; Scheel PJ
    Am J Kidney Dis; 1995 Feb; 25(2):228-34. PubMed ID: 7847349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy.
    Zhang R; Szerlip HM
    South Med J; 2000 Sep; 93(9):901-4. PubMed ID: 11005352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal failure and intravenous immune globulin: sucrose nephropathy in disguise?
    Perazella MA; Cayco AV
    Am J Ther; 1998 Nov; 5(6):399-403. PubMed ID: 10099084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy.
    Ahsan N
    J Nephrol; 1998; 11(3):157-61. PubMed ID: 9650125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
    Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
    Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.